Search Results
Douglas W. Blayney, MD, discusses the implications of the TAILORx study
Douglas W. Blayney, MD, discusses the biggest takeaway regarding breast cancer here at ASCO 2018
Douglas W. Blayney, MD, discusses the MONALEESA-3 study in HR+/HER2- advanced breast cancer
Douglas W. Blayney, MD, on differentiating CDK4/6 Inhibitors and if they can be used interchangeably
Sara M. Tolaney, MD, MPH, on whether the results of the TAILORx study are “practice changing”
TAILORx Study Explained by a Medical Oncologist
TAILORx: Patient-Reported Outcomes in Breast Cancer
Dr. Toomey Discusses Findings of TAILORx Trial
Douglas W. Blayney, MD Receives the Inaugural Ellen Stovall Award
TAILORx: Phase 3 trial validating a 21-gene expression assay in breast cancer
TAILORx
Julie Gralow, MD, discusses outcomes from the TAILORx study presented at ASCO 2018